EP2389932A1 — Compositions for use in genetic disorders comprising 4-phenyl-butyric acid and its salts
Assigned to Lunamed AG · Expires 2011-11-30 · 14y expired
What this patent protects
The present invention refers to pharmaceutical compositions comprising the histone hyperacetylating agent phenyl-butyric acid, or a physiologically acceptable salt thereof for use in the treatment of a genetic disorder, especially of an epigenetic disorder, like treatment of depr…
USPTO Abstract
The present invention refers to pharmaceutical compositions comprising the histone hyperacetylating agent phenyl-butyric acid, or a physiologically acceptable salt thereof for use in the treatment of a genetic disorder, especially of an epigenetic disorder, like treatment of depression, vaginitis and varicosis or the prevention of Sudden Infant Death Syndrome with a genetic disorder background.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.